The TP53 gene provides instructions for a protein called p53 that helps keep cell growth in check and responds when cells are damaged. This gene plays an important role in helping your body pause cell division to repair damage or clear out cells that are not working normally. When TP53 does not work well, damaged cells can keep growing, which can raise the chance of cancer over a lifetime. Certain inherited, harmful variants can cause Li-Fraumeni syndrome, a condition linked to higher risks of several cancer types, often at younger ages.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or regulate activities throughout the body. In some cases, a gene provides the blueprint for a protein, which carries out much of a cell’s day-to-day work. Other genes are more focused on guiding how biological processes are switched on, where they happen, and how intense they are. As a group, genes help direct growth and normal body function, and they can also influence how you react to food, stress, or medicines. More detail on this subject is available in the LearnHub.
Overview
TP53Gene function
What if the gene works
Your cells rely on the TP53 gene to make p53, a tumor suppressor protein. It helps pause cell division for DNA repair when damage occurs. If damage cannot be fixed, it can trigger cell death to reduce abnormal growth.
Risk
What if the gene does not work
If the TP53 gene does not work well, cells may be less able to control DNA damage, increasing risk for several cancers, often at younger ages (Li-Fraumeni syndrome). Effects can range from mild to severe, influencing how early cancers appear.
Treatment
What does that mean for your treatment
TP53 variants can affect cancer treatment, and clinicians often limit radiotherapy and some DNA-damaging chemotherapy when alternatives exist to reduce added DNA injury and second-cancer risk. Tumors with TP53 changes may respond differently, so drug selection is individualized.
Conditions associated with TP53
Gene function
What if the gene works
Your body constantly replaces cells, and each new cell needs careful checks before it keeps dividing. TP53 helps cells pause, inspect their DNA, and decide the safest next step. This is part of how the TP53 gene helps prevent cancer over a lifetime. In healthy cells, these responses stay balanced so tissues can renew without losing control.
TP53 helps cells slow down or pause division when conditions are not right for safe growth. This gives the cell time to confirm that it is ready to copy its genetic information accurately.
When DNA damage is detected, TP53 helps switch on protective programs inside the cell. These programs coordinate repair support and other safeguards so the cell can return to normal function.
If a cell is too damaged to safely continue, TP53 can guide it to self-destruct through apoptosis (a planned, tidy form of cell death). This helps remove cells that could otherwise disrupt healthy tissue renewal.
TP53 can push some stressed cells into senescence (a permanent stop in division). Senescent cells stay alive but no longer multiply, which can help keep tissue growth orderly.
What is a variant?
A genetic variant is a minor difference in the DNA code within a gene. These differences occur often and help explain normal variation among people, such as differences in appearance, metabolism, or the way the body reacts to environmental factors. Many variants do not lead to any obvious changes and are part of typical genetic diversity. In certain situations, though, a variant can affect how a gene works more strongly and may play a role in, or directly cause, a genetic condition.
Genetic variants
What if the gene does not work
Changes in the TP53 gene can weaken the cell’s ability to stop damaged cells from multiplying, so abnormal cells may survive and grow. Many TP53 changes are missense variants that make a faulty protein that can interfere with the normal copy, while other TP53 gene mutation types truncate the protein so little or none is made. DNA changes range from milder variants to severe mutations, which can influence how early cancers appear, how many different cancer types occur, and how quickly new tumors develop.
How variants are linked to conditions
Inherited changes in the TP53 gene cause Li-Fraumeni syndrome, which raises the chance of cancer at younger ages. Cancers most often linked include breast cancer, soft tissue and bone sarcomas, brain tumors, adrenocortical carcinoma, and leukemia. Many tumors also pick up TP53 changes during life, so a TP53 mutation may be found in tumor tissue without being inherited. A TP53 mutation Li-Fraumeni syndrome diagnosis can help tailor screening for you and sometimes relatives.
A variant is not necessarily a diagnosis
Gene variants are a routine feature of human biology and occur frequently across the general population. Many of these variants do not directly affect health and instead represent normal human diversity. For a large number of genes, having a variant that has been linked to a condition points to a potential association rather than a certain diagnosis, particularly when many genes and environmental influences contribute. In other situations, a single well-studied variant in a particular gene may be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
With a harmful change in the TP53 gene, lifetime cancer risk is very high and is mostly set by the gene change itself, so lifestyle steps cannot reliably lower it. Risk can still be influenced by exposures, so avoiding tobacco and limiting alcohol and unnecessary medical radiation can help reduce added risk. Regular, structured cancer screening and quick evaluation of new symptoms can improve early detection.
Inheritance of TP53 variants
Changes in the TP53 gene are most often inherited in an autosomal dominant pattern, meaning a person can inherit it from either parent. In families, TP53 gene variant inheritance means each child of a parent who carries the change has a 50% chance of inheriting it, regardless of sex. Sometimes the change happens for the first time in a child (de novo) rather than being inherited.
What does my TP53 result mean for my family?
Seek medical advice if you have a TP53 gene result and you’re worried about what it means for your children, siblings, or parents, or about the best timing and type of cancer screening. Get help right away if you notice possible cancer warning signs like a new lump, unexplained bleeding, or ongoing weight loss. A clinician can also explain whether your TP53 result could affect treatment choices for you or relatives.
Genetic information
Genetic testing
How you find out about variants
A genetic test can show whether you carry an inherited change in the TP53 gene linked to higher cancer risk. TP53 gene mutation testing is usually done on blood or saliva, where a lab reads the DNA sequence. Your report may label a variant as pathogenic, benign, or uncertain, and tumor results may need separate inherited testing.
When should I consider getting a genetic test?
Consider testing the TP53 gene if you or close relatives have had several different cancers, especially at unusually young ages. Testing can also be helpful with a strong family history of early breast cancer, sarcoma (cancer in bone or muscle), brain tumors, or certain childhood cancers, which can be part of Li-Fraumeni syndrome.
A genetic result is only one part of your health story
Genetic test results can be very informative, but what they reveal varies based on the condition and the specific type of variant. How your body functions over time is also shaped by many factors, including lifestyle, environment, age, and your medical history. For certain conditions, particularly those affected by many genes, genetic findings provide helpful background rather than a definite prediction and make the most sense when considered with the rest of your care. In other situations, a genetic result can offer a straightforward conclusion. For topics like how you respond to medications, genetic information can also help put your personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic changes in the TP53 gene, especially changes found in a tumor, can influence how cancer cells respond to certain cancer medicines that work by damaging a cell’s DNA or stopping cell growth. Because TP53 helps control how cells pause for repair or trigger cell death, some variants can make treatment effects stronger or weaker in different people. This is one reason the same medicine can work well for one person yet have less benefit or different side effects for another. Inherited TP53 variants mainly guide overall care planning, while tumor TP53 results are more directly tied to treatment response.
What is Pharmacogenetics?
Pharmacogenetics focuses on how variations in a person’s genes can affect the way they respond to medicines. It examines links between specific genes and particular drugs to explain why the same treatment can have different results in different people. With many medications, genetic factors can influence how powerfully a drug works or how the body breaks it down. Understanding these relationships can support more informed, more personalized treatment choices. More information on this subject is available in the LearnHub if you would like a deeper look.
Drugs influenced by the TP53 gene
When should I seek medical advice?
Seek medical advice if you or close relatives have had cancer at unusually young ages, several different cancers, or rare tumors. Get checked promptly for any new lump, unexplained bleeding, or ongoing pain. If a TP53 gene change is already known in your family, tell your care team because it may influence radiation use and follow-up plans.
History
The TP53 gene entered cancer research in 1979, when scientists identified a protein called p53 in tumor cells and virus-related studies. Early work led some researchers to think p53 promoted cancer, but by the late 1980s and early 1990s it became clear that many cancers carried damaged versions of the gene and that the normal gene helps protect against tumor formation. With each decade, genetic studies refined the picture. In 1990, inherited TP53 gene changes were linked to Li-Fraumeni syndrome, explaining why some families have multiple cancers at young ages. As large-scale tumor sequencing took off in the 2000s, TP53 became recognized as the most commonly altered gene across many cancer types, cementing its central role in modern cancer genetics.